2021 ICD-10-CM Diagnosis Code C83.70

Burkitt lymphoma, unspecified site

    2016 2017 2018 2019 2020 2021 Billable/Specific Code
  • C83.70 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2021 edition of ICD-10-CM C83.70 became effective on October 1, 2020.
  • This is the American ICD-10-CM version of C83.70 - other international versions of ICD-10 C83.70 may differ.
The following code(s) above C83.70 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C83.70:
  • C00-D49
    2021 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C81-C96
    2021 ICD-10-CM Range C81-C96

    Malignant neoplasms of lymphoid, hematopoietic and related tissue

    Type 2 Excludes
    • Kaposi's sarcoma of lymph nodes (C46.3)
    • secondary and unspecified neoplasm of lymph nodes (C77.-)
    • secondary neoplasm of bone marrow (C79.52)
    • secondary neoplasm of spleen (C78.89)
    Malignant neoplasms of lymphoid, hematopoietic and related tissue
  • C83
    ICD-10-CM Diagnosis Code C83

    Non-follicular lymphoma

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • personal history of non-Hodgkin lymphoma (Z85.72)
    Non-follicular lymphoma
  • C83.7
    ICD-10-CM Diagnosis Code C83.7

    Burkitt lymphoma

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Applicable To
    • Atypical Burkitt lymphoma
    • Burkitt-like lymphoma
    Type 1 Excludes
    • mature B-cell leukemia Burkitt type (C91.A-)
    Burkitt lymphoma
Approximate Synonyms
  • Burkitt lymphoma stage 1
  • Burkitt lymphoma stage 2
  • Burkitt lymphoma stage 3
  • Burkitt lymphoma stage 4
  • Burkitt's lymphoma (clinical)
  • Lymphoma, burkitts
  • Lymphoma, burkitts, stage 1
  • Lymphoma, burkitts, stage 2
  • Lymphoma, burkitts, stage 3
  • Lymphoma, burkitts, stage 4
Clinical Information
  • A form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of burkitt lymphoma. The epstein-barr virus (herpesvirus 4, human) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases; however, most non-african cases are ebv-negative.
  • A highly aggressive lymphoma composed of monomorphic medium-sized b-cells with basophilic cytoplasm and numerous mitotic figures. It is often associated with the presence of epstein-barr virus (ebv) and is commonly seen in aids patients. Three morphologic variants are recognized: classical burkitt lymphoma, burkitt lymphoma with plasmacytoid differentiation, and atypical burkitt/burkitt-like lymphoma. All cases express the myc translocation [t(8;14)]. (who, 2001)
  • A rare, fast-growing type of leukemia (blood cancer) in which too many white blood cells called b lymphocytes form in the blood and bone marrow. It may start in the lymph nodes as burkitt lymphoma and then spread to the blood and bone marrow, or it may start in the blood and bone marrow without involvement of the lymph nodes. Both burkitt leukemia and burkitt lymphoma have been linked to infection with the epstein-barr virus.
  • An aggressive (fast-growing) type of b-cell non-hodgkin lymphoma that occurs most often in children and young adults. The disease may affect the jaw, central nervous system, bowel, kidneys, ovaries, or other organs. There are three main types of burkitt lymphoma (sporadic, endemic, and immunodeficiency related). Sporadic burkitt lymphoma occurs throughout the world, and endemic burkitt lymphoma occurs in africa. Immunodeficiency-related burkitt lymphoma is most often seen in aids patients.
  • Form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world; commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass; b-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of burkitt lymphoma; the epstein-barr virus (human herpesvirus 4) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases, however, most non-african cases are ebv-negative.
  • The leukemic counterpart of burkitt's lymphoma. The characteristic burkitt cells are seen in the bone marrow and the peripheral blood. This is an aggressive leukemia.
ICD-10-CM C83.70 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):
  • 820 Lymphoma and leukemia with major o.r. Procedures with mcc
  • 821 Lymphoma and leukemia with major o.r. Procedures with cc
  • 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
  • 823 Lymphoma and non-acute leukemia with other procedures with mcc
  • 824 Lymphoma and non-acute leukemia with other procedures with cc
  • 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
  • 840 Lymphoma and non-acute leukemia with mcc
  • 841 Lymphoma and non-acute leukemia with cc
  • 842 Lymphoma and non-acute leukemia without cc/mcc
  • 974 Hiv with major related condition with mcc
  • 975 Hiv with major related condition with cc
  • 976 Hiv with major related condition without cc/mcc

Convert C83.70 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
ICD-10-CM Codes Adjacent To C83.70
C83.51 …… lymph nodes of head, face, and neck
C83.52 …… intrathoracic lymph nodes
C83.53 …… intra-abdominal lymph nodes
C83.54 …… lymph nodes of axilla and upper limb
C83.55 …… lymph nodes of inguinal region and lower limb
C83.56 …… intrapelvic lymph nodes
C83.57 …… spleen
C83.58 …… lymph nodes of multiple sites
C83.59 …… extranodal and solid organ sites
C83.7 Burkitt lymphoma
C83.70 …… unspecified site
C83.71 …… lymph nodes of head, face, and neck
C83.72 …… intrathoracic lymph nodes
C83.73 …… intra-abdominal lymph nodes
C83.74 …… lymph nodes of axilla and upper limb
C83.75 …… lymph nodes of inguinal region and lower limb
C83.76 …… intrapelvic lymph nodes
C83.77 …… spleen
C83.78 …… lymph nodes of multiple sites
C83.79 …… extranodal and solid organ sites
C83.8 Other non-follicular lymphoma

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.